{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:37:51Z","timestamp":1793659071094,"version":"4.5.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.clinthera.2023.12.005","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T15:45:44Z","timestamp":1704987944000},"page":"104-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Efficacy and Safety of CSF-1 (0.4% Pilocarpine Hydrochloride) in Presbyopia: Pooled Results of the NEAR Phase 3 Randomized, Clinical Trials"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7732-3172","authenticated-orcid":false,"given":"Edward","family":"Holland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Karpecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Fingeret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Schaeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Ignacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lindstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2023.12.005_bib0001","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.ophtha.2018.04.013","article-title":"Global prevalence of presbyopia and vision impairment from uncorrected presbyopia","volume":"125","author":"Fricke","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0002","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1350-9462(03)00063-6","article-title":"Mechanical properties of the human lens capsule","volume":"22","author":"Krag","year":"2003","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0003","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.ophtha.2015.04.014","article-title":"The global burden of potential productivity loss from uncorrected presbyopia","volume":"122","author":"Frick","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0004","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/aos.12308","article-title":"Review of the impact of presbyopia on quality of life in the developing and developed world","volume":"92","author":"Goertz","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0005","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/ceo.12954","article-title":"Impact of refractive error on quality of life","volume":"45","author":"Kandel","year":"2017","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0006","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.preteyeres.2018.09.004","article-title":"Presbyopia: effectiveness of correction strategies","volume":"68","author":"Wolffsohn","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0007","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/ICU.0000000000000864","article-title":"Pilocarpine 1.25% and the changing landscape of presbyopia treatment","volume":"33","author":"Meghpara","year":"2022","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0008","unstructured":"Vuity [package insert]. North Chicago, Ill: Allergan, an AbbVie Company; 2022."},{"key":"10.1016\/j.clinthera.2023.12.005_bib0009","first-page":"10781","article-title":"Pharmacological treatment of presbyopia: a systematic review","volume":"32","author":"Haghpanah","year":"2002","journal-title":"Eur J Transl Myol"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/ICU.0000000000000770","article-title":"Pharmacological strategies for treating presbyopia","volume":"32","author":"Orman","year":"2021","journal-title":"Curr Open Ophthalmol"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0011","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0161-6420(98)99053-4","article-title":"Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery","volume":"105","author":"Flach","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0012","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/jop.1995.11.361","article-title":"Safety and efficacy of diclofenac sodium 0.1% ophthalmic solution in acute seasonal allergic conjunctivitis","volume":"11","author":"Laibovitz","year":"1995","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0013","unstructured":"Orasis Pharmaceuticals Ltd. Safety, tolerability and efficacy of PresbiDrops (CSF-1) in presbyopic subjects. 2016. https:\/\/ClinicalTrials.gov\/show\/NCT02965664. Accessed November 30, 2023"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0014","first-page":"1385","article-title":"Drops for presbyopia: Results of CSF-1, a multicenter randomized double-masked placebo-controlled crossover study","volume":"60","author":"Socea","year":"2019","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0015","series-title":"Paper presented at: 2022 American Society of Cataract and Refractive Surgery Annual Meeting","article-title":"Phase 2b clinical trial to evaluate the safety and efficacy of CSF-1 for the treatment of presbyopia","author":"Farid","year":"2022"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0016","unstructured":"Isopto Carpine [package insert]. Fort Worth, Tex: Alcon Laboratories, Inc; 2010."},{"key":"10.1016\/j.clinthera.2023.12.005_bib0017","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/bjo.52.8.607","article-title":"Influence of pH on the effect of pilocarpine on aqueous dynamics","volume":"52","author":"Anderson","year":"1968","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0018","series-title":"Development of a low dose pilocarpine ophthalmic formulation that is stable, well-tolerated and bioavailable at a near neutral pH for the treatment of presbyopia. Poster presented at 2022 American Association of Pharmaceutical Scientists","author":"Amzel-Sasson","year":"2022"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0019","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3390\/jcm11051385","article-title":"Pharmacological treatment in presbyopia","volume":"11","author":"Grzybowski","year":"2002","journal-title":"J Clin Med"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0020","series-title":"GEMINI 1 & 2 Pooled Phase 3: the proportion of subjects with clinically meaningful near vision improvement. Paper presented at 2022 American Society of Cataract and Refractive Surgery Annual Meeting","author":"Rocha","year":"2022"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0021","series-title":"Interpreting clinically meaningful near vision improvement in presbyopia with AGN-190584 in the GEMINI 1 Phase 3 trial. Paper presented at the 2021 American Academy of Optometry","author":"Evans","year":"2021"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0022","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jamaophthalmol.2022.0059","article-title":"Safety and efficacy of AGN-190584 in individuals with presbyopia: The GEMINI 1 phase 3 randomized clinical trial","volume":"140","author":"Waring","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0023","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3928\/1081-597X-20071001-03","article-title":"Near visual acuity for everyday activities with accommodative and monofocal intraocular lenses","volume":"23","author":"Sanders","year":"2007","journal-title":"J Refract Surg"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0024","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ajo.2022.05.011","article-title":"Retinal detachments associated with topical pilocarpine use for presbyopia","volume":"242","author":"Al-Khersan","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0025","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3928\/23258160-20220629-01","article-title":"Vitreofoveal traction associated with pilocarpine for presbyopia","volume":"53","author":"Amarikwa","year":"2022","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.clinthera.2023.12.005_bib0026","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/ICB.0000000000001309","article-title":"Rhegmatogenous retinal detachment after initiation of pilocarpine hydrochloride ophthalmic solution 1.25% for treatment of presbyopia","volume":"18","author":"Eaton","year":"2024","journal-title":"Retin Cases Brief Rep"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823004782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823004782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T09:01:25Z","timestamp":1758963685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291823004782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0149291823004782"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.12.005","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of CSF-1 (0.4% Pilocarpine Hydrochloride) in Presbyopia: Pooled Results of the NEAR Phase 3 Randomized, Clinical Trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}